Similar articles for PMID: 26564323

Year	Number of Results
1992	1
1996	1
1997	1
2000	1
2002	3
2003	3
2004	4
2005	3
2006	6
2007	5
2008	2
2009	1
2010	4
2011	4
2012	2
2013	5
2014	4
2015	8
2016	4
2017	11
2018	7
2019	8
2020	2
2021	6
2022	9
2023	2
2024	0

1

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.

Herrmann K, Schottelius M, Lapa C, Osl T, Poschenrieder A, Hänscheid H, Lückerath K, Schreder M, Bluemel C, Knott M, Keller U, Schirbel A, Samnick S, Lassmann M, Kropf S, Buck AK, Einsele H, Wester HJ, Knop S. Herrmann K, et al. J Nucl Med. 2016 Feb;57(2):248-51. doi: 10.2967/jnumed.115.167361. Epub 2015 Nov 12. J Nucl Med. 2016. PMID: 26564323 Free article.

2

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.

Osl T, Schmidt A, Schwaiger M, Schottelius M, Wester HJ. Osl T, et al. Theranostics. 2020 Jul 9;10(18):8264-8280. doi: 10.7150/thno.45537. eCollection 2020. Theranostics. 2020. PMID: 32724470 Free PMC article.

3

[¹⁷⁷Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.

Schottelius M, Osl T, Poschenrieder A, Hoffmann F, Beykan S, Hänscheid H, Schirbel A, Buck AK, Kropf S, Schwaiger M, Keller U, Lassmann M, Wester HJ. Schottelius M, et al. Theranostics. 2017 Jun 11;7(9):2350-2362. doi: 10.7150/thno.19119. eCollection 2017. Theranostics. 2017. PMID: 28744319 Free PMC article.

4

Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.

Maurer S, Herhaus P, Lippenmeyer R, Hänscheid H, Kircher M, Schirbel A, Maurer HC, Buck AK, Wester HJ, Einsele H, Grigoleit GU, Keller U, Lapa C. Maurer S, et al. J Nucl Med. 2019 Oct;60(10):1399-1405. doi: 10.2967/jnumed.118.223420. Epub 2019 Mar 8. J Nucl Med. 2019. PMID: 30850502 Free PMC article.

5

[⁶⁸Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [¹⁸F]FDG and laboratory values.

Lapa C, Schreder M, Schirbel A, Samnick S, Kortüm KM, Herrmann K, Kropf S, Einsele H, Buck AK, Wester HJ, Knop S, Lückerath K. Lapa C, et al. Theranostics. 2017 Jan 1;7(1):205-212. doi: 10.7150/thno.16576. eCollection 2017. Theranostics. 2017. PMID: 28042328 Free PMC article.

6

Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease.

Chen Z, Xue Q, Yao S. Chen Z, et al. Mini Rev Med Chem. 2023;23(7):787-803. doi: 10.2174/1389557523666221216095821. Mini Rev Med Chem. 2023. PMID: 36529918 Review.

7

CXCR4-targeted theranostics in oncology.

Buck AK, Serfling SE, Lindner T, Hänscheid H, Schirbel A, Hahner S, Fassnacht M, Einsele H, Werner RA. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4133-4144. doi: 10.1007/s00259-022-05849-y. Epub 2022 Jun 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 35674738 Free PMC article. Review.

8

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [⁶⁸Ga]Ga-Pentixafor /[¹⁷⁷Lu]Lu-Pentixather.

Jacobs SM, Wesseling P, de Keizer B, Tolboom N, Ververs FFT, Krijger GC, Westerman BA, Snijders TJ, Robe PA, van der Kolk AG. Jacobs SM, et al. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):481-491. doi: 10.1007/s00259-021-05196-4. Epub 2021 Feb 7. Eur J Nucl Med Mol Imaging. 2022. PMID: 33550492 Free PMC article.

9

Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.

Bluemel C, Hahner S, Heinze B, Fassnacht M, Kroiss M, Bley TA, Wester HJ, Kropf S, Lapa C, Schirbel A, Buck AK, Herrmann K. Bluemel C, et al. Clin Nucl Med. 2017 Jan;42(1):e29-e34. doi: 10.1097/RLU.0000000000001435. Clin Nucl Med. 2017. PMID: 27819856

10

CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma.

Lapa C, Herrmann K, Schirbel A, Hänscheid H, Lückerath K, Schottelius M, Kircher M, Werner RA, Schreder M, Samnick S, Kropf S, Knop S, Buck AK, Einsele H, Wester HJ, Kortüm KM. Lapa C, et al. Theranostics. 2017 Apr 8;7(6):1589-1597. doi: 10.7150/thno.19050. eCollection 2017. Theranostics. 2017. PMID: 28529638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year